Table 2.
Class | KEGG pathway | Median ko-abundance | |||
---|---|---|---|---|---|
(ko number) | Pathway | H. pylori | H. pylori | ||
negative (n = 34) | positive (n = 13) | Pb | |||
M | ko00072† | Synthesis and degradation of ketone bodies | 1335885.8 | 1823878.4 | <0.05 |
M | ko00380† | Tryptophan metabolism | 2254680.9 | 2759405.6 | <0.05 |
M | ko00510 | N-glycan biosynthesis | 907554.4 | 700748.0 | <0.05 |
M | ko00565a | Ether lipid metabolism | 150966.1 | 394815.2 | <0.001 |
M | ko00571 | Lipoarabinomannan (LAM) biosynthesis | 397200.0 | 191311.5 | <0.05 |
M | ko00591a | Linoleic acid metabolism | 85148.3 | 389478.0 | <0.001 |
M | ko00592a | alpha-Linolenic acid metabolism | 132544.9 | 405656.4 | <0.001 |
M | ko00780a | Biotin metabolism | 15103400 | 19564468 | <0.05 |
M | ko00906a | Carotenoid biosynthesis | 129310.3 | 510048.5 | <0.01 |
M | ko00940† | Phenylpropanoid biosynthesis | 348411.2 | 598460.1 | <0.01 |
M | ko01053 | Biosynthesis of siderophore group nonribosomal peptides | 2025414.2 | 1127312.8 | <0.01 |
M | ko01062a | Biosynthesis of terpenoids and steroids | 92469.4 | 428251.7 | <0.01 |
Twelve metabolic pathways that significantly differed among 327 detected pathways. M, metabolism. aMost abundant pathways in H. pylori-positive group. bCalculated using Mann–Whitney U tests